Axsome Therapeutics (AXSM) Shares Issued: 2022-2025
Historic Shares Issued for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to $9.9 million.
- Axsome Therapeutics' Shares Issued fell 24.08% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.6 million, marking a year-over-year increase of 35.33%. This contributed to the annual value of $40.8 million for FY2024, which is 84.24% down from last year.
- Axsome Therapeutics' Shares Issued amounted to $9.9 million in Q3 2025, which was down 69.52% from $32.6 million recorded in Q2 2025.
- Over the past 5 years, Axsome Therapeutics' Shares Issued peaked at $211.3 million during Q2 2023, and registered a low of $387,000 during Q1 2023.
- For the 3-year period, Axsome Therapeutics' Shares Issued averaged around $34.8 million, with its median value being $14.8 million (2024).
- Its Shares Issued has fluctuated over the past 5 years, first crashed by 98.75% in 2023, then soared by 685.69% in 2025.
- Over the past 4 years, Axsome Therapeutics' Shares Issued (Quarterly) stood at $180.2 million in 2022, then plummeted by 81.27% to $33.8 million in 2023, then slumped by 61.18% to $16.4 million in 2024, then dropped by 24.08% to $9.9 million in 2025.
- Its Shares Issued stands at $9.9 million for Q3 2025, versus $32.6 million for Q2 2025 and $19.6 million for Q1 2025.